根据 Gen Consulting 公司发布的市场研究报告, the market size of the global therapeutic biologics sector is expected to rise by USD 170 亿，复合年增长率为 7.7% 到年底 2028.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global therapeutic biologics market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the therapeutic biologics industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对产品的详细分析, 和地区. The global market for therapeutic biologics can be segmented by product: therapeutic proteins, 疫苗, 其他的. The therapeutic proteins segment was the largest contributor to the global therapeutic biologics market in 2021. Therapeutic biologics market is further segmented by region: 亚太地区, 欧洲, 北美, 事物 (中东和非洲), 拉美. 据研究, North America had the largest share in the global therapeutic biologics market.

副产品:
– therapeutic proteins
– 疫苗
– 其他的

按地区:
– 亚太地区
– 欧洲
– 北美
– 事物 (中东和非洲)
– 拉美

The report explores the recent developments and profiles of key vendors in the Global Therapeutic Biologics Market, including Amgen Inc., Baxter International Inc., China Biologic Products Holdings, 公司, CSL Ltd., 伊利礼来公司, 葛兰素史克公司 (葛兰素史克公司), Grifols, S.A., Kedrion S.p.A., 诺华公司, Octapharma AG, Reliance Life Sciences, 罗氏控股公司, 赛诺菲公司, 梯瓦制药工业有限公司, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global therapeutic biologics market.
– To classify and forecast the global therapeutic biologics market based on product, 地区.
– To identify drivers and challenges for the global therapeutic biologics market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global therapeutic biologics market.
– To identify and analyze the profile of leading players operating in the global therapeutic biologics market.

为什么选择这份报告
– Gain a reliable outlook of the global therapeutic biologics market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.